Loading Crop Life Science…
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 207 | 200 | 198 | 131 | — |
| Operating profit | 12 | 11 | 9 | 8 | — |
| Operating margin | 5.9% | 5.5% | 4.8% | 6.4% | — |
| Net profit | 7 | 6 | 6 | 4 | — |
| Net margin | 3.2% | 2.9% | 3.0% | 3.1% | — |
| EPS (₹) | — | 3.44 | 3.51 | 2.38 | 1.64 |
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Total assets | 208 | 182 | 180 | 102 |
| Total liabilities | 120 | 100 | 104 | 61 |
| Shareholders’ equity | 84 | 77 | 72 | 41 |
| Total debt | 57 | 44 | 35 | 27 |
| Cash & equivalents | 1 | 1 | 2 | 0 |
| Debt / equity | 0.67 | 0.57 | 0.49 | 0.67 |
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Operating cash flow | -8 | -1 | -8 | 2 |
| Capital expenditure | -2 | -4 | -7 | -5 |
| Free cash flow | -10 | -5 | -16 | -3 |
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Return on equity | 7.9% | 7.6% | 8.4% | 10.0% |
| Return on assets | 3.2% | 3.2% | 3.3% | 4.0% |
| Net margin | 3.2% | 2.9% | 3.0% | 3.1% |
Source: Yahoo Finance. Figures in ₹ crore unless stated.
No analyst data available for CLSL. Finnhub coverage is limited for some India-listed stocks.